Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: A randomized, investigator-blinded study

Dermatology

Volumn 224, Issue 1, 2012, Pages 31-37

  Del Giglio, Micol ^a   Gisondi, Paolo ^a   Tessari, Gianpaolo ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Body mass index; Disease remission; Low calorie diet; Obesity; Psoriasis

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET; DISEASE SEVERITY; FEMALE; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; REMISSION; WEIGHT REDUCTION;

ADULT; AGED; BODY MASS INDEX; DERMATOLOGIC AGENTS; DIET, REDUCING; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; OBESITY; PSORIASIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84861101404     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000335566     Document Type: Article

References (45)

1. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM: Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835.
2. Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP: Cardiovascular risk factors in patients with plaque psoriasis: A systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24(suppl 2):23-30.
3. Micciolo R, Di Francesco V, Fantin F, Canal L, Harris TB, Bosello O, Zamboni M: Prevalence of overweight and obesity in Italy (2001-2008): Is there a rising obesity epidemic? Ann Epidemiol 2010; 20: 258-264.
4. Setty AR, Curhan G, Choi HK: Obesity, waist circumference, weight change, and the risk of psoriasis in women. Arch Intern Med 2007; 167: 1670-1675.
5. Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG: Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010; 146: 721-726.
6. Huerta C, Rivero E, Rodríguez LA: Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-1565.
7. Bremmer S, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF Jr, Blauvelt A: Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010; 63: 1058-1069.
8. Gisondi P, Targher G, Zoppini G, Girolomoni G: Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009; 51: 758-764.
9. Gisondi P, Farina S, Giordano MV, Girolomoni G: Usefulness of the Framingham risk score in patients with chronic psoriasis. Am J Cardiol 2010; 106: 1754-1757.
10. Rosenberg P, Urwitz H, Johannesson A, Ros AM, Kinnman N, Hultcrantz R: Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol 2007; 46: 1111-1118.
11. Thaçi D, Bräutigam M, Kaufmann R, Weidinger G, Paul C, Christophers E: Bodyweight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study. Dermatology 2002; 205: 383-388.
12. Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, Maccarone M, Chatenoud L, Bertuccio P, Caggese E, Cuscito R: Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology 2008; 217: 365-373.
13. Clark L, Lebwohl M: The effect of weight on the efficacy of biologic therapy in patients with psoriasis. J Am Acad Dermatol 2008; 58: 443-436.
14. Higa-Sansone G, Szomstein S, Soto F, Brasecsco O, Cohen C, Rosenthal RJ: Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14: 1132-1134.
15. De Menezes Ettinger JE, Azaro E, de Souza CA, dos Santos Filho PV, Mello CA, Neves M Jr, de Amaral PC, Fahel E: Remission of psoriasis after open gastric bypass. Obes Surg 2006; 16: 94-97.
16. Hossler EW, Maroon MS, Mowad CM: Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 2011; 65: 198-200.
17. Gisondi P, Del Giglio M, Di Francesco V, Zamboni M, Girolomoni G: Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: A randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008; 88: 1242-1247.
18. Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Del Giglio M, Di Francesco V, Barillari M, Pozzi Mucelli R, Zamboni M: Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity 2011; 19: 1747-1754.
19. Harris JA, Benedict FG: A Biometric Study of Basal Metabolism in Man. Washington, Carnegie Institute, 1919.
20. Gordon KB, Feldman SR, Koo JYM, Menter A, Rostald T, Krueger G: Definition of measures of effect duration for psoriasis treatments. Arch Dermatol 2005; 141: 82-84.
21. Naldi L, Chatenoud L, Linder D, et al: Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67.
22. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG: Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
23. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G: Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
24. Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK: Prevalence of the metabolic syndrome in psoriasis: Results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011; 147: 419-424.
25. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB: Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol 2009; 34: 140-144.
26. Balci A, Balci DD, Yonden Z, Korkmaz I, Yenin JZ, Celik E, Okumus N, Egilmez E: Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome. Dermatology 2010; 220: 32-37.
27. Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue. An update. Clin Endocrinol 2006; 64: 355-365.
28. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumié A: Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747.
29. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
30. Davidovici B, Sattar N, Prinz J, Puig L, Emery P, Barker J, van de Kerkhof P, Ståhle M, Nestle F, Girolomoni G, Krueger J: Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
31. Clark L, Lebwohl M: The effect of weight on the efficacy of biologic therapy in patients with psoriasis. Am Acad Dermatol 2008; 58: 443-446.
32. Puig L: Obesity and psoriasis: Body weight and body mass index influence the response to biological treatment. J Eur Acad Dermatol Venereol 2011; 25: 1007-1011.
33. Lithell H, Bruce A, Gustafsson IB, Hoglund NJ, Karlstrom B, Ljunghall K, Sjölin K, Venge P, Werner I, Vessby B: A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Derm Venereol 1983; 63: 397-403.
34. Maniscalco M, Zedda A, Faraone S, Cerbone MR, Cristiano S, Giardiello C, Sofia M: Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008; 102: 102-108.
35. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Førre O: Controlled trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet 1991; 338: 899-902.
36. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Førre O: Vegetarian diet for patients with rheumatoid arthritis - status: Two years after introduction of the diet. Clin Rheumatol 1994; 13: 475-482.
37. Koo J, Lebwohl M: Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51-59.
38. Van Dooren-Greebe RJ, Kuijpers AL, Termoshuizen F, van de Kerkhof PC: Interruption of long term methotrexate treatment in psoriasis: Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate. Acta Derm Venereol (Stockh) 1995; 75: 393-396.
39. Sarwer DB, von Sydow Green A, Vetter ML, Wadden TA: Behavior therapy for obesity: where are we now? Curr Opin Endocrinol Diabetes Obes 2009; 16: 347-352.
40. US Department of Health and Human Services: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report. NIH Publication 98-4083, 1998.
41. Wadden TA, Butryn ML, Wilson C: Lifestyle modification for the management of obesity. Gastroenterology 2007; 132: 2226-2238.
42. Antuna-Puente B, Feve B, Fellahi S, Bastard JP: Adipokines: The missing link between insulin resistance and obesity. Diabetes Metab 2008; 34: 2-11.
43. Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B: Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: A 3-year weight loss study. Eur J Endocrinol 2008; 158: 179-187.
44. Jung SH, Park HS, Kim KS, Choi WH, Ahn CW, Kim BT, Kim SM, Lee SY, Ahn SM, Kim YK, Kim HJ, Kim DJ, Lee KW: Effect of weight loss on some serum cytokines in human obesity: Increase in IL-10 after weight loss. J Nutr Biochem 2008; 19: 371-375.
45. Bacon L, Aphramor L: Weight science: Evaluating the evidence for a paradigm shift. Nutr J 2011; 24: 10-19.